General Information of Drug Transporter (DT)
DT ID DTD0546 Transporter Info
Gene Name KCNK9
Transporter Name Potassium channel subfamily K member 9
Gene ID
51305
UniProt ID
Q9NPC2
Post-Translational Modification of This DT
Overview of KCNK9 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNK9 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

144

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at KCNK9 Lysine 144 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNK9 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

53

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at KCNK9 Asparagine 53 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNK9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

127

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNK9 Serine 127 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence KCNK9 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

317

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNK9 Serine 317 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNK9 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

121

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNK9 Threonine 121 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence KCNK9 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

134

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNK9 Threonine 134 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence KCNK9 [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

113

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNK9 Tyrosine 113 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence KCNK9 [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

138

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at KCNK9 Tyrosine 138 has the potential to affect its expression or activity.
References
1 Effect of ethinyl estradiol and triton WR 1339 on bile formation and sulfobromophthalein transport maximum (BSPTm) in the rat. Pharmacol Res Commun. 1981 Nov;13(10):903-8.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: KCNK9_HUMAN)
3 In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
4 A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res. 2012 Nov 2;11(11):5311-22.
5 Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells. Retrovirology. 2018 Jul 3;15(1):44.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.